NZ208959A - Insulin derivatives and pharmaceutical compositions - Google Patents
Insulin derivatives and pharmaceutical compositionsInfo
- Publication number
- NZ208959A NZ208959A NZ208959A NZ20895984A NZ208959A NZ 208959 A NZ208959 A NZ 208959A NZ 208959 A NZ208959 A NZ 208959A NZ 20895984 A NZ20895984 A NZ 20895984A NZ 208959 A NZ208959 A NZ 208959A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pharmaceutical compositions
- insulin derivatives
- insulin
- derivatives
- pharmaceutical
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical class N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/622—Insulins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833326472 DE3326472A1 (de) | 1983-07-22 | 1983-07-22 | Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ208959A true NZ208959A (en) | 1989-02-24 |
Family
ID=6204660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ208959A NZ208959A (en) | 1983-07-22 | 1984-07-20 | Insulin derivatives and pharmaceutical compositions |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4701440A (enExample) |
| EP (1) | EP0132770B1 (enExample) |
| JP (2) | JPS6042397A (enExample) |
| AR (1) | AR241864A1 (enExample) |
| AT (1) | ATE29729T1 (enExample) |
| AU (1) | AU569097B2 (enExample) |
| CA (1) | CA1246548A (enExample) |
| DE (2) | DE3326472A1 (enExample) |
| DK (2) | DK172211B1 (enExample) |
| ES (2) | ES534487A0 (enExample) |
| FI (1) | FI79854C (enExample) |
| GR (1) | GR81551B (enExample) |
| HU (1) | HUT37805A (enExample) |
| IE (1) | IE57709B1 (enExample) |
| IL (1) | IL72469A (enExample) |
| NO (1) | NO167810C (enExample) |
| NZ (1) | NZ208959A (enExample) |
| PH (1) | PH23014A (enExample) |
| PT (1) | PT78940A (enExample) |
| ZA (1) | ZA845620B (enExample) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3327928A1 (de) * | 1983-08-03 | 1985-02-21 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von insulin-derivaten |
| DE3333640A1 (de) * | 1983-09-17 | 1985-04-25 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung |
| DE3501641A1 (de) * | 1985-01-19 | 1986-07-24 | Hoechst Ag, 6230 Frankfurt | Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen |
| US4946828A (en) * | 1985-03-12 | 1990-08-07 | Novo Nordisk A/S | Novel insulin peptides |
| DK113585D0 (da) * | 1985-03-12 | 1985-03-12 | Novo Industri As | Nye peptider |
| US4764592A (en) * | 1987-04-23 | 1988-08-16 | Eli Lilly And Company | Crystalline human proinsulin and process for its production |
| DE3717370A1 (de) * | 1987-05-22 | 1988-12-01 | Hoechst Ag | Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus |
| US4789660A (en) * | 1987-09-10 | 1988-12-06 | American Home Products Corporation | Insulin administration using methyl and propyl paraben |
| DE3827533A1 (de) * | 1988-08-13 | 1990-02-15 | Hoechst Ag | Pharmazeutische zubereitung zur behandlung des diabetes mellitus |
| DE3837825A1 (de) * | 1988-11-08 | 1990-05-10 | Hoechst Ag | Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
| US5716927A (en) * | 1988-12-23 | 1998-02-10 | Novo Nordisk A/S | Insulin analogs having a modified B-chain |
| HUT56857A (en) * | 1988-12-23 | 1991-10-28 | Novo Nordisk As | Human insulin analogues |
| DK134189D0 (da) * | 1989-03-20 | 1989-03-20 | Nordisk Gentofte | Insulinforbindelser |
| DE3936876A1 (de) * | 1989-11-06 | 1991-05-23 | Hoechst Ag | Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung |
| WO1992010284A2 (en) | 1990-12-07 | 1992-06-25 | Cnc Development, Inc. | Catalytic chemical reactor |
| YU66892A (sh) * | 1991-08-20 | 1995-10-24 | Hoechst Ag. | Fosfoinositolglikan - peptid sa delovanjem kao insulin |
| TW224471B (enExample) * | 1991-11-26 | 1994-06-01 | Lilly Co Eli | |
| DK0545198T3 (da) * | 1991-11-29 | 2000-03-20 | Hoechst Ag | Peptider med insulinagtig virkning |
| US5504188A (en) * | 1994-06-16 | 1996-04-02 | Eli Lilly And Company | Preparation of stable zinc insulin analog crystals |
| PT821006E (pt) | 1996-07-26 | 2004-09-30 | Aventis Pharma Gmbh | Derivados de insulina com ligacao a zinco aumentada |
| DE19649350A1 (de) * | 1996-11-28 | 1998-06-04 | Hoechst Ag | Inositolglykane mit insulinartiger Wirkung |
| US6444641B1 (en) | 1997-10-24 | 2002-09-03 | Eli Lilly Company | Fatty acid-acylated insulin analogs |
| DE19825447A1 (de) | 1998-06-06 | 1999-12-09 | Hoechst Marion Roussel De Gmbh | Neue Insulinanaloga mit erhöhter Zinkbildung |
| JP4969002B2 (ja) | 1999-06-08 | 2012-07-04 | ユニバーシテイ・オブ・アイオワ・リサーチ・フアウンデーシヨン | ｒＡＡＶ形質導入を増加するための化合物および方法 |
| WO2002067969A2 (en) | 2001-02-21 | 2002-09-06 | Medtronic Minimed, Inc. | Stabilized insulin formulations |
| US6605155B2 (en) * | 2001-02-21 | 2003-08-12 | Seiwa Pro Co., Ltd. | Remover for scale deposited on titanium material |
| DE10114178A1 (de) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität |
| DE10227232A1 (de) * | 2002-06-18 | 2004-01-15 | Aventis Pharma Deutschland Gmbh | Saure Insulinzubereitungen mit verbesserter Stabilität |
| WO2004089423A2 (en) | 2003-03-31 | 2004-10-21 | University Of Iowa Research Foundation | Pharmico-gene theraphy of epithelial sodium channel associated disoders |
| JP2008500006A (ja) * | 2003-05-21 | 2008-01-10 | バイオテック トゥールス ソシエテ アノニム | ペプチド複合体 |
| US7833513B2 (en) | 2004-12-03 | 2010-11-16 | Rhode Island Hospital | Treatment of Alzheimer's Disease |
| PT3228320T (pt) | 2008-10-17 | 2020-03-26 | Sanofi Aventis Deutschland | Combinação de uma insulina e de um agonista do glp-1 |
| PH12011502708B1 (en) | 2009-07-06 | 2017-11-10 | Sanofi Aventis Deutschland | Insulin preparations containing methionine |
| JP5832439B2 (ja) | 2009-11-13 | 2015-12-16 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | Ｇｌｐ−１アゴニスト、インスリン及びメチオニンを含む薬学的組成物 |
| SG10201500871TA (en) | 2009-11-13 | 2015-04-29 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a glp-1 agonist and methionine |
| CN103179978A (zh) | 2010-08-30 | 2013-06-26 | 赛诺菲-安万特德国有限公司 | Ave0010用于制造供治疗2型糖尿病用的药物的用途 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| JP6367115B2 (ja) | 2011-08-29 | 2018-08-01 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | ２型糖尿病患者の血糖コントロールに使用する組合せ医薬 |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| CN107206058A (zh) | 2014-12-12 | 2017-09-26 | 赛诺菲-安万特德国有限公司 | 甘精胰岛素/利西拉来固定比率配制剂 |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
| WO2017139381A1 (en) | 2016-02-08 | 2017-08-17 | University Of Iowa Research Foundation | Methods to produce chimeric adeno-associated virus/bocavirus parvovirus |
| WO2017155973A1 (en) | 2016-03-07 | 2017-09-14 | University Of Iowa Research Foundation | Aav-mediated expression using a synthetic promoter and enhancer |
| US12173305B2 (en) | 2016-05-26 | 2024-12-24 | University Of Iowa Research Foundation | cis and trans requirements for terminal resolution of human bocavirus 1 |
| US11142775B2 (en) | 2017-01-13 | 2021-10-12 | University Of Iowa Research Foundation | Bocaparvovirus small noncoding RNA and uses thereof |
| EP3852873A1 (en) | 2018-09-19 | 2021-07-28 | Ziylo Ltd | Glucose sensitive insulins and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2256215C3 (de) * | 1972-11-16 | 1981-01-08 | Hoechst Ag, 6000 Frankfurt | Insulin-Zubereitung mit einem Gehalt an kristallinem Insulin und amorphem Desphenylalanin8' -insulin |
| DE2460753A1 (de) * | 1974-12-21 | 1976-06-24 | Hoechst Ag | Verfahren zur herstellung von humaninsulin |
| NO153061C (no) * | 1979-04-13 | 1986-01-08 | Shionogi & Co | Fremgangsmaate for fremstilling av et b30-threonininsulin |
| DK319780A (da) * | 1980-07-24 | 1982-01-25 | Forenede Bryggerier As | Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner |
| DE3209184A1 (de) * | 1982-03-13 | 1983-09-15 | Hoechst Ag, 6230 Frankfurt | Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen |
| NL8201650A (nl) * | 1982-04-21 | 1983-11-16 | Akzo Nv | Semisynthetische bereiding van humane insuline. |
| DE3327928A1 (de) * | 1983-08-03 | 1985-02-21 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von insulin-derivaten |
| DE3333640A1 (de) * | 1983-09-17 | 1985-04-25 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung |
| DE3334407A1 (de) * | 1983-09-23 | 1985-04-04 | Hoechst Ag, 6230 Frankfurt | In position b 30 modifizierte insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus |
| JPH118546A (ja) * | 1997-04-24 | 1999-01-12 | Hitachi Ltd | Ｃｍｏｓ回路 |
-
1983
- 1983-07-22 DE DE19833326472 patent/DE3326472A1/de not_active Withdrawn
-
1984
- 1984-07-16 HU HU842766A patent/HUT37805A/hu unknown
- 1984-07-17 AR AR84297267A patent/AR241864A1/es active
- 1984-07-18 DE DE8484108442T patent/DE3466227D1/de not_active Expired
- 1984-07-18 EP EP84108442A patent/EP0132770B1/de not_active Expired
- 1984-07-18 GR GR75343A patent/GR81551B/el unknown
- 1984-07-18 AT AT84108442T patent/ATE29729T1/de not_active IP Right Cessation
- 1984-07-19 PT PT78940A patent/PT78940A/pt not_active IP Right Cessation
- 1984-07-19 FI FI842914A patent/FI79854C/fi not_active IP Right Cessation
- 1984-07-20 DK DK358284A patent/DK172211B1/da not_active IP Right Cessation
- 1984-07-20 NZ NZ208959A patent/NZ208959A/xx unknown
- 1984-07-20 IE IE1889/84A patent/IE57709B1/en not_active IP Right Cessation
- 1984-07-20 AU AU30922/84A patent/AU569097B2/en not_active Ceased
- 1984-07-20 ES ES534487A patent/ES534487A0/es active Granted
- 1984-07-20 JP JP59149784A patent/JPS6042397A/ja active Granted
- 1984-07-20 ZA ZA845620A patent/ZA845620B/xx unknown
- 1984-07-20 CA CA000459386A patent/CA1246548A/en not_active Expired
- 1984-07-20 NO NO842977A patent/NO167810C/no not_active IP Right Cessation
- 1984-07-20 PH PH31009A patent/PH23014A/en unknown
- 1984-07-20 IL IL72469A patent/IL72469A/xx not_active IP Right Cessation
- 1984-09-06 ES ES535706A patent/ES535706A0/es active Granted
-
1986
- 1986-06-06 US US06/873,456 patent/US4701440A/en not_active Expired - Lifetime
-
1989
- 1989-02-22 JP JP1040427A patent/JPH01294634A/ja active Granted
-
1990
- 1990-01-04 DK DK001790A patent/DK172209B1/da not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL72028A (en) | Aminomethyl-oxo-oxazolidinylbenzene derivatives and pharmaceutical compositions containing them | |
| NZ220345A (en) | Imidazoquinolinylether derivatives and pharmaceutical compositions containing them | |
| IL72566A (en) | Androst-5-en-17-one and 5alpha-androstan-17-one derivatives and pharmaceutical compositions containing the same | |
| IL71967A (en) | Drug administration composition | |
| NZ207885A (en) | Phenethanolamine derivatives and pharmaceutical compositions | |
| EP0138421A3 (en) | Hydroxypyridinone derivatives and pharmaceutical compositions containing them | |
| NZ209759A (en) | Pyrrolidinone derivatives and pharmaceutical compositions thereof | |
| NZ211031A (en) | 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions | |
| NZ210633A (en) | Glycerol derivatives and pharmaceutical compositions thereof | |
| IL71249A0 (en) | Thiazolidine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL74865A0 (en) | 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them | |
| PH22334A (en) | Cephalosporin derivatives and pharmaceutical composition containing same | |
| NZ209064A (en) | N 6 -diarylalkyl-adenosine derivatives and pharmaceutical compositions | |
| NZ210105A (en) | Oxazolidine derivatives and pharmaceutical compositions | |
| IL76188A (en) | 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them | |
| NZ209095A (en) | Piperidinoquinazolines and pharmaceutical compositions | |
| NZ210818A (en) | 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions | |
| NZ225466A (en) | 1-aminoalkyl-1h-indole derivatives and pharmaceutical compositions containing certain derivatives thereof | |
| IL72157A (en) | 6-alpha-hydroxyethyl-2-substituted-2-penem-3-carboxylic acid derivatives and pharmaceutical compositions comprising them | |
| GB2167414B (en) | Flavolignan derivatives and pharmaceutical compositions containing them | |
| NZ208244A (en) | Phenyl-pyrazol-3-ones and pharmaceutical compositions | |
| DE3473444D1 (en) | Acylindole derivatives and pharmaceutical compositions containing them | |
| NZ208694A (en) | Rooperol derivatives and pharmaceutical compositions | |
| PH19575A (en) | Cephalosporing derivatives and pharmaceutical compositions thereof | |
| IL73224A (en) | 2-dioxacycloalkylthiopenem derivatives and pharmaceutical compositions containing them |